Crossmark

Metachronous immune-related adverse events involving type 1 diabetes and isolated adrenocorticotropic hormone deficiency associated with pembrolizumab monotherapy for metastatic head and neck cancer: a case report

Crossref DOI link: https://doi.org/10.1186/s13256-023-04106-6

Published Online: 2023-09-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Iijima, Hiroaki https://orcid.org/0000-0002-3343-9111
Sakai, Akihiro

Ebisumoto, Koji

Yamauchi, Mayu

Teramura, Takanobu

Yamazaki, Aritomo

Inagi, Toshihide

Okami, Kenji
License Information

Text and Data Mining valid from 2023-09-12

Version of Record valid from 2023-09-12
More Information

Article History

Received: 4 January 2023

Accepted: 30 July 2023

First Online: 12 September 2023

Declarations

:

: This study was conducted in accordance with the principles of the Declaration of Helsinki.

: Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below